New imaging system integrates 4K, 3D, and fluorescence-guided technologies across multiple surgical specialties.
Olympus Corp of the Americas has launched the Visera Elite III surgical imaging platform in the United States, expanding its portfolio of imaging systems for minimally invasive procedures.
The platform, developed through the SONY Olympus Medical joint venture, integrates multiple imaging technologies into a single system designed to support surgical visualization and workflow across a range of specialties.
According to Olympus, the system combines features such as True 4K and 3D imaging, Continuous Auto Focus, Narrow Band Imaging, Yellow Enhancement, and Fluorescence-Guided Surgery. These capabilities are intended to support visualization during minimally invasive procedures and assist with clinical decision-making.
The Visera Elite III platform is designed for use across specialties including arthroscopy, colorectal, ENT, bariatric, thoracic, gynecological, urological, hepatobiliary, transplant, and general surgery. The system is also compatible with prior-generation Olympus videoendoscopes, allowing facilities to continue using existing equipment.
“Visera Elite III is more than a platform; it’s a strategic enabler for modern operating rooms and is a cornerstone of Olympus’ SEE. TREAT. CONNECT.™ ecosystem,” says Darryl Rock, vice president and surgical solutions regional business lead at Olympus Corp of the Americas, in a release. “Its software-based architecture allows hospitals to scale capabilities while controlling capital investment and selectively activate advanced features like 3D and infrared imaging as needed. By seamlessly integrating data into electronic health records and IT systems, Visera Elite III may facilitate flexibility and clinical workflow and enable clinicians to focus on what matters most, delivering high-quality care while optimizing their investment.”
Anatomical Visualization and Surgical Precision
The company also highlighted features intended to support visualization of anatomical structures and surgical precision, including imaging modes designed to enhance contrast and fluorescence visibility. Survey data cited by Olympus indicated that a majority of surgeons reported Yellow Enhancement may assist in identifying vessels, nerves, and other structures within adipose tissue.
“With use of indocyanine green during surgery, I can see the perfusion of the connection clearly, and I can continue dissecting with confidence,” says Natan Zundel, MD, FACS, FASMBS, bariatric and metabolic surgeon with Jackson Health in Miami, Florida, in a release.
Olympus says the platform is designed to support operating room standardization by enabling use across multiple specialties, which may reduce the need for separate systems. The system also includes integration with Olympus software platforms for video capture, documentation, and connectivity with electronic health records.
The Visera Elite III imaging platform is now available globally, including in the United States. It will be exhibited at SAGES 2026, scheduled for March 25–28 in Tampa, Florida.
Photo caption: The Visera Elite III surgical imaging platform offers features including Yellow Enhancement and Fluorescence-Guided Surgery in full 4K White Light and high-contrast Magenta Mode, as shown above.
Photo credit: Olympus Corp
